Brind.

Tilray and Curaleaf are reported to dominate the cannabis pharmaceuticals market.

2 reports, 1 independent Updated Jul 29

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Tilray and Curaleaf are reported to dominate the cannabis pharmaceuticals market.

Who's involved

What this event is mainly about

Tilray Curaleaf

Keep exploring

The entities involved

Tilray
pharmaceutical and cannabis company

Nothing else this week.
Curaleaf
Canadian cannabis company
- Matt Martinez comments on vape industry standards while Jessie Kater explains the cannabis extraction process.Tue 01:39
- Curaleaf launched an unsolicited takeover bid for Aurora, which is listed on the Nasdaq stock exchange.Mon 12:41

Coverage

Newest first; wire copies grouped

Jul 29GlobeNewswireCannabis Pharmaceuticals Market Report 2025-2029 and 2034 Featuring Leading Players - Curaleaf, Aphria, Green Thumb Industries, Trulieve Cannabis Corp, and Tilray This Cannabis Pharmaceuticals market
Jul 29GlobeNewswireCannabis-Infused Products Market Analysis Report 2025-2029 and 2034 | E-Commerce Surge Boosting Expansion, SoRSE Emulsion Technology Enhancing Cannabis Beverage Experience The Cannabis-Infused Produc